Biopharma Contract Market Update

CMOs and CDMOs expanded their services and facilities in 2019 and early 2020.

Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) continue to grow and expand to keep up with the latest advances and breakthroughs in services and technology for their clients. The following are some notable acquisitions, expansions, and industry partnerships that have occurred in recent months.

Read this article in BioPharm International’s Outsourcing Resources February 2020 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources, February 2020
February 2020
Pages: 28–30

Citation

When referring to this article, please cite it as The Editors of BioPharm International, “Biopharma Contract Market Update," BioPharm International Outsourcing Resources eBook (February 2020).

Articles in this issue

over 5 years ago

Article

Lyophilization Services Gain Ground Amid Growing Biologics Market

over 5 years ago

Article

Building Strategic Relationships with CROs

over 5 years ago

Article

Digitalization: A CDMO’s Perspective

over 5 years ago

Article

More Capacity and Technology Translate to More Options

over 5 years ago

Article

Sourcing Success in Cell and Gene Therapy Development

over 5 years ago

Article

Using the “Cubic Effect” to Drive Cell and Gene Therapy Commercialization

over 5 years ago

Article

Growth in Biologics Market Inspires Outsourcing

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!